期刊文献+

阿托伐他汀治疗血脂异常180例疗效观察 被引量:1

Observation of the curative effect of atorvastatin in 180 cases of blood- lipid abnormality
下载PDF
导出
摘要 目的观察阿托伐他汀治疗血脂异常患者调脂强度及不良反应。方法对180例血脂异常患者随机分为两组即服阿托伐他汀组(10mg每日1次)和服辛他汀组(10mg每晚1次),8周后复查血脂,用t检验和x2检验行统计学处理。结果两组治疗前后组内比较,TC、TG、LDL-C差异均有显著性(P<0.05),HDL-C差异无显著性(P>0.05)。组间比较TC、LDL-C差异有显著性(P<0.05),TG、HDL-C差异无显著性(P>0.05)。结论阿托伐他汀治疗血脂异常调脂作用确切,是进行冠心病一、二级预防的理想调脂药。
作者 张向隆
出处 《现代医药卫生》 2005年第9期1053-1053,共1页 Journal of Modern Medicine & Health
  • 相关文献

参考文献2

二级参考文献17

  • 1[1]Otto C,Richter WO,Schwandt P.Contribution of fibrinogen and lipoproteins to plasma viscosity in hybercholesterolemia and hypertriglyceridemia:evaluation by selective depletion of low- density lipoproteins or fibrinogen.Metabolism,2000,49(6):810
  • 2[3]Ejima J,Ijichi T,Ohnishi Y.Relationship between high- den_ sity lipoprotein cholesterol and red blood cell filterability; cross- sectional study of healthy subjects.Clin Hemorheol Mi_ crocirc,2000,22(1):1
  • 3[4]Gianturco SH,Bradley WA.Pathophisiology of triglyceride- rich lipoproteins in atherothrombosis:cellular aspects.Clin Cardiol,1999,22(6):117
  • 4[6]Scalia R,Appel JZ,Lefer AM.Leukocyte- endothelium inter_ action during the early stages of hypercholesterolemia in the rabbit:role of P- selection,ICAM,and VCAM- 1.Arterioscler Thromb Vasc Biol,1998,18(7):1093
  • 5[7]Pratico D,Cyrus T,Li H,FitzGerald GA.Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis.Blood,2000,96(12):3823
  • 6[8]Sobal G,Sinzinger H.Prostaglandins and lipid modification. Curr Pharm Des,2001,7(6):461
  • 7[9]Nofer JR,Tepel M,Kehrel B,et al.Low- density lipoprotein inhibit the Na+ /H+ transport in human platelets.A novel mechanism enhancing platelets activity in hypercholes_ terolemia.Circulation,1997,95:1370
  • 8[10]Sanders TA,Miller GJ,De GrassT,et al.Postprandial activa_ tion of coagulant factor Ⅶ by long- chain dietary fatty acids. Thromb Haemost,1996,76:369
  • 9[11]Sawka Am,Singh RJ,Hiddinga HJ.Remnant lipoproteins in_ clude endothelial plasminogen actibator inhibitor- 1.Biochem Biophys Res Commun,2001,285(1):15
  • 10[12]Tabengwa EM,Benza RL,Grenett HE.Hypertriglyceridemic down- regulates tissue plasminogen activator gene transcrip_ tion trhough cis- repressibe regions in the tissue plasminogen activator promoter in cultured human endothelial cells.Arter_ ioscler Thromb Vasc,Biol,2000,20(6):1675

共引文献25

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部